FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

KONINKLIJKE PHILIPS NV 		2. Issuer Name and Ticker or Trading Symbol

Corindus Vascular Robotics, Inc. [ CVRS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/22/2017
(Street)

AMSTERDAM, P7 
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share   12/15/2017     A    9174   (1) A $0.00   26368032   (1) I   See footnote   (2)
Common Stock, par value $0.0001 per share   5/31/2018     A    53326   (3) A $0.7501   26421358   (4) I   See footnote   (2)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified stock option (right to buy)   $1.68   6/22/2017     A      17857         (5) 6/21/2027   Common Stock   17857   $0.00   17857   I   See footnote   (2)

Explanation of Responses:
(1)  The common stock represents shares issuable upon vesting of restricted stock units ("RSUs") granted to Nathan Harrington in his capacity as a director of Corindus Vascular Robotics, Inc. (the "Issuer") as part of his 2017 annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The RSUs provide for vesting in quarterly installments on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with the Issuer.
(2)  These securities are held directly by Nathan Harrington, an employee of the reporting person, as compensation for his service as a director of the Issuer. Pursuant to Mr. Harrington's arrangement with the reporting person as his employer, any compensation received by Mr. Harrington during his service as a director of the Issuer is for the benefit of the reporting person and, as such, Mr. Harrington intends to transfer his securities to the reporting person for no consideration.
(3)  The common stock represents shares issuable upon vesting of RSUs granted to Mr. Harrington in his capacity as a director of the Issuer as part of his 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to Mr. Harrington's continuous service with the Issuer through each such vesting date.
(4)  Includes 9,174 shares of common stock related to RSUs granted as part of Mr. Harrington's 2017 annual equity award which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with Issuer through each such vesting date
(5)  The underlying shares vest over a period of three years with 33.33% vesting on the first anniversary of the issuance date and 8.334% vesting at the end of each calendar quarter thereafter.

Remarks:
Mr. Harrington is an employee of the reporting person and serves as a director of the Issuer. As a result, the reporting person may be deemed a director by deputization for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
KONINKLIJKE PHILIPS NV
PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC
AMSTERDAM, P7  		X X


Signatures
/s/ Abhijit Bhattacharya, Chief Financial Officer 3/15/2019
** Signature of Reporting Person Date

/s/ Marnix van Ginneken, Chief Legal Officer 3/15/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Corindus Vascular Robotics Charts.
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Corindus Vascular Robotics Charts.